LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile

[1]  W. Couser.  Basic and translational concepts of immune-mediated glomerular diseases. , 2012, Journal of the American Society of Nephrology : JASN.

[2]  D. Stechschulte,et al.  Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells , 2012, Mediators of inflammation.

[3]  M. Lanaspa,et al.  Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Richard J. Johnson,et al.  Minimal change disease: a CD80 podocytopathy? , 2011, Seminars in nephrology.

[5]  Xuebing Ding,et al.  Numb Protects Renal Proximal Tubular Cells from Puromycin Aminonucleoside-Induced Apoptosis through Inhibiting Notch Signaling Pathway , 2011, International journal of biological sciences.

[6]  K. Taranta-Janusz,et al.  Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria , 2011, Scandinavian journal of urology and nephrology.

[7]  C. Rivard,et al.  Minimal change disease: a “two-hit” podocyte immune disorder? , 2011, Pediatric Nephrology.

[8]  M. Sánchez-Niño,et al.  TNF Superfamily: A Growing Saga of Kidney Injury Modulators , 2010, Mediators of inflammation.

[9]  A. Kistler,et al.  Maximal 'CD80-uria' with minimal change. , 2010, Kidney international.

[10]  Mark L. Johnson,et al.  Prostaglandin E2 is crucial in the response of podocytes to fluid flow shear stress , 2010, Journal of Cell Communication and Signaling.

[11]  S. Gay,et al.  TLRs and chronic inflammation. , 2010, The international journal of biochemistry & cell biology.

[12]  C. Harrison,et al.  Scavenger receptor A1 is required for sensing HCMV by endosomal TLR-3/-9 in monocytic THP-1 cells. , 2010, Molecular immunology.

[13]  H. Anders,et al.  Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll‐like receptor 2 at the glomerular filtration barrier , 2009, Immunology.

[14]  J. Lane,et al.  Pediatric nephrotic syndrome: from the simple to the complex. , 2009, Seminars in nephrology.

[15]  S. Shankland,et al.  Inducible rodent models of acquired podocyte diseases. , 2009, American journal of physiology. Renal physiology.

[16]  Ying Sun,et al.  Glomerular Transcriptome Changes Associated with Lipopolysaccharide-Induced Proteinuria , 2009, American Journal of Nephrology.

[17]  D. Hackam,et al.  No Longer an Innocent Bystander: Epithelial Toll-Like Receptor Signaling in the Development of Mucosal Inflammation , 2008, Molecular medicine.

[18]  E. Bock,et al.  TLR4 links podocytes with the innate immune system to mediate glomerular injury. , 2008, Journal of the American Society of Nephrology : JASN.

[19]  P. Tipping.  Are podocytes passive or provocative in proteinuric glomerular pathology? , 2008, Journal of the American Society of Nephrology : JASN.

[20]  Holger Heine,et al.  Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling , 2008, Journal of leukocyte biology.

[21]  J. Sedor,et al.  Activation of adenosine 2A receptors preserves structure and function of podocytes. , 2008, Journal of the American Society of Nephrology : JASN.

[22]  P. Mathieson.  Minimal change nephropathy and focal segmental glomerulosclerosis , 2007, Seminars in Immunopathology.

[23]  R. Woroniecki,et al.  Urinary Cytokines and Steroid Responsiveness in Idiopathic Nephrotic Syndrome of Childhood , 2007, American Journal of Nephrology.

[24]  E. Haddad,et al.  A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. , 2007, Journal of the American Society of Nephrology : JASN.

[25]  W. Buurman,et al.  Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. , 2007, Journal of the American Society of Nephrology : JASN.

[26]  H. Anders,et al.  Toll-like receptors: emerging concepts in kidney disease , 2007, Current opinion in nephrology and hypertension.

[27]  R. Carmody,et al.  Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. , 2007, Cellular & molecular immunology.

[28]  S. Shankland,et al.  Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo. , 2006, Kidney international.

[29]  Tapasi C Saha,et al.  Minimal Change Disease: A Review , 2006, Southern medical journal.

[30]  T. Golper,et al.  Downloadable computer models for maintenance but not acute renal replacement therapy. , 2006, Kidney international.

[31]  M. Segal,et al.  A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome , 2006, Pediatric Nephrology.

[32]  R. Kalluri,et al.  Induction of B7-1 in podocytes is associated with nephrotic syndrome. , 2004, The Journal of clinical investigation.

[33]  A. DeFranco,et al.  Ligand-regulated Chimeric Receptor Approach Reveals Distinctive Subcellular Localization and Signaling Properties of the Toll-like Receptors* , 2004, Journal of Biological Chemistry.

[34]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[35]  A. Yamamoto,et al.  Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells , 2003, The Journal of Immunology.

[36]  S. Akira,et al.  TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway , 2003, Nature Immunology.

[37]  P. Godowski,et al.  Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines , 2002, The Journal of Immunology.

[38]  A. Visintin,et al.  Toll‐like receptor 1 inhibits Toll‐like receptor 4 signaling in endothelial cells , 2002, European journal of immunology.

[39]  M. O'hare,et al.  A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.

[40]  W. Smoyer,et al.  Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  P. Godowski,et al.  Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines , 2002, The Journal of Immunology.

[42]  H. Pavenstädt,et al.  Reactive oxygen species alter gene expression in podocytes: induction of granulocyte macrophage-colony-stimulating factor. , 2002, Journal of the American Society of Nephrology : JASN.

[43]  K. Uchida,et al.  Puromycin aminonucleoside induces apoptosis and increases HNE in cultured glomerular epithelial cells11Portions of this work were presented at the meeting of American Society of Nephrology and International Society of Nephrology (2001), and have been published in abstract form. , 2001 .

[44]  A. Aderem,et al.  Cutting Edge: Functional Interactions Between Toll-Like Receptor (TLR) 2 and TLR1 or TLR6 in Response to Phenol-Soluble Modulin1 , 2001, The Journal of Immunology.

[45]  K. Uchida,et al.  Puromycin aminonucleoside induces apoptosis and increases HNE in cultured glomerular epithelial cells(1). , 2001, Free Radical Biology & Medicine.

[46]  S. Reitinger,et al.  Amino acid transport in podocytes. , 2000, American journal of physiology. Renal physiology.

[47]  J. G. van den Berg,et al.  Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. , 2000, Journal of the American Society of Nephrology : JASN.

[48]  S. Jordan,et al.  Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. , 1999, Journal of the American Society of Nephrology : JASN.

[49]  T. Srivastava,et al.  High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood , 1999, Pediatric Nephrology.

[50]  S. Fujimoto,et al.  Cell Proliferation and Apoptosis of the Glomerular Epithelial Cells in Rats with Puromycin Aminonucleoside Nephrosis , 1998, Pathobiology.

[51]  V. Savin,et al.  TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide. , 1998, Journal of the American Society of Nephrology : JASN.

[52]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[53]  T. Kodama.  [Scavenger receptor]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[54]  T. Barratt,et al.  Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome. , 1994, Archives of disease in childhood.

[55]  J. Weening,et al.  Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization, but not protein synthesis of cultured glomerular epithelial cells. , 1994, Experimental nephrology.

[56]  B. Myers,et al.  Elevated Levels of Tumor Necrosis Factor-α in the Nephrotic Syndrome in Humans , 1993 .

[57]  B. Myers,et al.  Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  N. MacDonald,et al.  Role of respiratory viruses in exacerbations of primary nephrotic syndrome. , 1986, The Journal of pediatrics.

[59]  J. Bonventre,et al.  A role for oxygen free radicals in aminonucleoside nephrosis. , 1986, Kidney international.

[60]  R. Lannigan.  The production of chronic renal disease in rats by a single intravenous injection of aminonucleoside of puromycin and the effect of low dosage continuous hydrocortisone. , 1963, British journal of experimental pathology.

[61]  J. Craig,et al.  Experimental Nephrotic Syndrome Induced in Rats by Aminonucleoside. Renal Lesions and Body Electrolyte Composition.∗ , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.